• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Relapse-free survival as a surrogate for overall survival in the evaluation of stage II-III melanoma adjuvant therapy.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    djx133.pdf
    Size:
    946.5Kb
    Format:
    PDF
    Description:
    Full text, Open Access article
    Download
    Authors
    Suciu, S
    Eggermont, A
    Lorigan, Paul C
    Kirkwood, J
    Markovic, S
    Garbe, C
    Cameron, D
    Kotapati, S
    Chen, T
    Wheatley, K
    Ives, N
    de Schaetzen, G
    Efendi, A
    Buyse, M
    Show allShow less
    Affiliation
    European Organisation for Research and Treatment of Cancer Headquarters, Brussels, Belgium
    Issue Date
    2018-01-01
    
    Metadata
    Show full item record
    Abstract
    We assessed whether relapse-free survival (RFS; time until recurrence/death) is a valid surrogate for overall survival (OS) among resected stage II-III melanoma patients through a meta-analysis of randomized controlled trials.
    Citation
    Relapse-free survival as a surrogate for overall survival in the evaluation of stage II-III melanoma adjuvant therapy. 2018, 110 (1): J Natl Cancer Inst
    Journal
    Journal of the National Cancer Institute
    URI
    http://hdl.handle.net/10541/620624
    DOI
    10.1093/jnci/djx133
    PubMed ID
    28922786
    Type
    Article
    Language
    en
    ISSN
    1460-2105
    ae974a485f413a2113503eed53cd6c53
    10.1093/jnci/djx133
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.
    • Authors: Eggermont AM, Suciu S, Testori A, Kruit WH, Marsden J, Punt CJ, Santinami M, Salès F, Schadendorf D, Patel P, Dummer R, Robert C, Keilholz U, Yver A, Spatz A
    • Issue date: 2012 Jan
    • Indirect treatment comparison of nivolumab versus placebo as adjuvant treatment for resected melanoma.
    • Authors: Weber JS, Ascierto PA, Middleton MR, Hennicken D, Zoffoli R, Pieters A, Amadi A, Kupas K, Kotapati S, Moshyk A, Schadendorf D
    • Issue date: 2021 Nov
    • Long-term results of the randomized phase III trial EORTC 18991 of adjuvant therapy with pegylated interferon alfa-2b versus observation in resected stage III melanoma.
    • Authors: Eggermont AM, Suciu S, Testori A, Santinami M, Kruit WH, Marsden J, Punt CJ, Salès F, Dummer R, Robert C, Schadendorf D, Patel PM, de Schaetzen G, Spatz A, Keilholz U
    • Issue date: 2012 Nov 1
    • Adjuvant ipilimumab versus placebo after complete resection of stage III melanoma: long-term follow-up results of the European Organisation for Research and Treatment of Cancer 18071 double-blind phase 3 randomised trial.
    • Authors: Eggermont AMM, Chiarion-Sileni V, Grob JJ, Dummer R, Wolchok JD, Schmidt H, Hamid O, Robert C, Ascierto PA, Richards JM, Lebbe C, Ferraresi V, Smylie M, Weber JS, Maio M, Hosein F, de Pril V, Kicinski M, Suciu S, Testori A
    • Issue date: 2019 Sep
    • Evaluating the potential of relapse-free survival as a surrogate for overall survival in the adjuvant therapy of melanoma with checkpoint inhibitors.
    • Authors: Coart E, Suciu S, Squifflet P, Saad ED, Moshyk A, de Schaetzen G, Buyse M, Weber JS, Eggermont A, Kotapati S
    • Issue date: 2020 Sep
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.